Global Intermediate CDMO Supply, Demand and Key Producers, 2023-2029
The global Intermediate CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Intermediate CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intermediate CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intermediate CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intermediate CDMO total market, 2018-2029, (USD Million)
Global Intermediate CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Intermediate CDMO total market, key domestic companies and share, (USD Million)
Global Intermediate CDMO revenue by player and market share 2018-2023, (USD Million)
Global Intermediate CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Intermediate CDMO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Intermediate CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pharmira, AGC Inc, Blue Jet Healthcare, Drug Discovery Alliances, KriSan Biotech, Saurav Chemicals, Olon SpA, AGC Biologics and Fermion, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intermediate CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Intermediate CDMO Market, By Region:
1. How big is the global Intermediate CDMO market?
2. What is the demand of the global Intermediate CDMO market?
3. What is the year over year growth of the global Intermediate CDMO market?
4. What is the total value of the global Intermediate CDMO market?
5. Who are the major players in the global Intermediate CDMO market?
6. What are the growth factors driving the market demand?
This report studies the global Intermediate CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intermediate CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intermediate CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intermediate CDMO total market, 2018-2029, (USD Million)
Global Intermediate CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Intermediate CDMO total market, key domestic companies and share, (USD Million)
Global Intermediate CDMO revenue by player and market share 2018-2023, (USD Million)
Global Intermediate CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Intermediate CDMO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Intermediate CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pharmira, AGC Inc, Blue Jet Healthcare, Drug Discovery Alliances, KriSan Biotech, Saurav Chemicals, Olon SpA, AGC Biologics and Fermion, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intermediate CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Intermediate CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Antibiotic Intermediates
- Antipyretic and Analgesic Intermediate
- Cardiovascular System Drug Intermediates
- Anticancer Drug Intermediates
- Pharmaceutical Company
- Biotechnology Company
- Generic Company
- Others
- Pharmira
- AGC Inc
- Blue Jet Healthcare
- Drug Discovery Alliances
- KriSan Biotech
- Saurav Chemicals
- Olon SpA
- AGC Biologics
- Fermion
- Pfizer CentreOne
- Aspen Holdings
- Educell
- Hovione
- Porton Pharma Solutions
- Sinopep
- Chongqing Huapont Pharmaceutical
- Langhua Pharmaceutical
1. How big is the global Intermediate CDMO market?
2. What is the demand of the global Intermediate CDMO market?
3. What is the year over year growth of the global Intermediate CDMO market?
4. What is the total value of the global Intermediate CDMO market?
5. Who are the major players in the global Intermediate CDMO market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Intermediate CDMO Introduction
1.2 World Intermediate CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Intermediate CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Intermediate CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Intermediate CDMO Market Size (2018-2029)
1.3.3 China Intermediate CDMO Market Size (2018-2029)
1.3.4 Europe Intermediate CDMO Market Size (2018-2029)
1.3.5 Japan Intermediate CDMO Market Size (2018-2029)
1.3.6 South Korea Intermediate CDMO Market Size (2018-2029)
1.3.7 ASEAN Intermediate CDMO Market Size (2018-2029)
1.3.8 India Intermediate CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intermediate CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intermediate CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Intermediate CDMO Consumption Value (2018-2029)
2.2 World Intermediate CDMO Consumption Value by Region
2.2.1 World Intermediate CDMO Consumption Value by Region (2018-2023)
2.2.2 World Intermediate CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Intermediate CDMO Consumption Value (2018-2029)
2.4 China Intermediate CDMO Consumption Value (2018-2029)
2.5 Europe Intermediate CDMO Consumption Value (2018-2029)
2.6 Japan Intermediate CDMO Consumption Value (2018-2029)
2.7 South Korea Intermediate CDMO Consumption Value (2018-2029)
2.8 ASEAN Intermediate CDMO Consumption Value (2018-2029)
2.9 India Intermediate CDMO Consumption Value (2018-2029)
3 WORLD INTERMEDIATE CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Intermediate CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Intermediate CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Intermediate CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Intermediate CDMO in 2022
3.3 Intermediate CDMO Company Evaluation Quadrant
3.4 Intermediate CDMO Market: Overall Company Footprint Analysis
3.4.1 Intermediate CDMO Market: Region Footprint
3.4.2 Intermediate CDMO Market: Company Product Type Footprint
3.4.3 Intermediate CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Intermediate CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Intermediate CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Intermediate CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Intermediate CDMO Consumption Value Comparison
4.2.1 United States VS China: Intermediate CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Intermediate CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Intermediate CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Intermediate CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Intermediate CDMO Revenue, (2018-2023)
4.4 China Based Companies Intermediate CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Intermediate CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Intermediate CDMO Revenue, (2018-2023)
4.5 Rest of World Based Intermediate CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Intermediate CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Intermediate CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Intermediate CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antibiotic Intermediates
5.2.2 Antipyretic and Analgesic Intermediate
5.2.3 Cardiovascular System Drug Intermediates
5.2.4 Anticancer Drug Intermediates
5.3 Market Segment by Type
5.3.1 World Intermediate CDMO Market Size by Type (2018-2023)
5.3.2 World Intermediate CDMO Market Size by Type (2024-2029)
5.3.3 World Intermediate CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Intermediate CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Generic Company
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Intermediate CDMO Market Size by Application (2018-2023)
6.3.2 World Intermediate CDMO Market Size by Application (2024-2029)
6.3.3 World Intermediate CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pharmira
7.1.1 Pharmira Details
7.1.2 Pharmira Major Business
7.1.3 Pharmira Intermediate CDMO Product and Services
7.1.4 Pharmira Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pharmira Recent Developments/Updates
7.1.6 Pharmira Competitive Strengths & Weaknesses
7.2 AGC Inc
7.2.1 AGC Inc Details
7.2.2 AGC Inc Major Business
7.2.3 AGC Inc Intermediate CDMO Product and Services
7.2.4 AGC Inc Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 AGC Inc Recent Developments/Updates
7.2.6 AGC Inc Competitive Strengths & Weaknesses
7.3 Blue Jet Healthcare
7.3.1 Blue Jet Healthcare Details
7.3.2 Blue Jet Healthcare Major Business
7.3.3 Blue Jet Healthcare Intermediate CDMO Product and Services
7.3.4 Blue Jet Healthcare Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Blue Jet Healthcare Recent Developments/Updates
7.3.6 Blue Jet Healthcare Competitive Strengths & Weaknesses
7.4 Drug Discovery Alliances
7.4.1 Drug Discovery Alliances Details
7.4.2 Drug Discovery Alliances Major Business
7.4.3 Drug Discovery Alliances Intermediate CDMO Product and Services
7.4.4 Drug Discovery Alliances Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Drug Discovery Alliances Recent Developments/Updates
7.4.6 Drug Discovery Alliances Competitive Strengths & Weaknesses
7.5 KriSan Biotech
7.5.1 KriSan Biotech Details
7.5.2 KriSan Biotech Major Business
7.5.3 KriSan Biotech Intermediate CDMO Product and Services
7.5.4 KriSan Biotech Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 KriSan Biotech Recent Developments/Updates
7.5.6 KriSan Biotech Competitive Strengths & Weaknesses
7.6 Saurav Chemicals
7.6.1 Saurav Chemicals Details
7.6.2 Saurav Chemicals Major Business
7.6.3 Saurav Chemicals Intermediate CDMO Product and Services
7.6.4 Saurav Chemicals Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Saurav Chemicals Recent Developments/Updates
7.6.6 Saurav Chemicals Competitive Strengths & Weaknesses
7.7 Olon SpA
7.7.1 Olon SpA Details
7.7.2 Olon SpA Major Business
7.7.3 Olon SpA Intermediate CDMO Product and Services
7.7.4 Olon SpA Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Olon SpA Recent Developments/Updates
7.7.6 Olon SpA Competitive Strengths & Weaknesses
7.8 AGC Biologics
7.8.1 AGC Biologics Details
7.8.2 AGC Biologics Major Business
7.8.3 AGC Biologics Intermediate CDMO Product and Services
7.8.4 AGC Biologics Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 AGC Biologics Recent Developments/Updates
7.8.6 AGC Biologics Competitive Strengths & Weaknesses
7.9 Fermion
7.9.1 Fermion Details
7.9.2 Fermion Major Business
7.9.3 Fermion Intermediate CDMO Product and Services
7.9.4 Fermion Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Fermion Recent Developments/Updates
7.9.6 Fermion Competitive Strengths & Weaknesses
7.10 Pfizer CentreOne
7.10.1 Pfizer CentreOne Details
7.10.2 Pfizer CentreOne Major Business
7.10.3 Pfizer CentreOne Intermediate CDMO Product and Services
7.10.4 Pfizer CentreOne Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Pfizer CentreOne Recent Developments/Updates
7.10.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.11 Aspen Holdings
7.11.1 Aspen Holdings Details
7.11.2 Aspen Holdings Major Business
7.11.3 Aspen Holdings Intermediate CDMO Product and Services
7.11.4 Aspen Holdings Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Aspen Holdings Recent Developments/Updates
7.11.6 Aspen Holdings Competitive Strengths & Weaknesses
7.12 Educell
7.12.1 Educell Details
7.12.2 Educell Major Business
7.12.3 Educell Intermediate CDMO Product and Services
7.12.4 Educell Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Educell Recent Developments/Updates
7.12.6 Educell Competitive Strengths & Weaknesses
7.13 Hovione
7.13.1 Hovione Details
7.13.2 Hovione Major Business
7.13.3 Hovione Intermediate CDMO Product and Services
7.13.4 Hovione Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Hovione Recent Developments/Updates
7.13.6 Hovione Competitive Strengths & Weaknesses
7.14 Porton Pharma Solutions
7.14.1 Porton Pharma Solutions Details
7.14.2 Porton Pharma Solutions Major Business
7.14.3 Porton Pharma Solutions Intermediate CDMO Product and Services
7.14.4 Porton Pharma Solutions Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Porton Pharma Solutions Recent Developments/Updates
7.14.6 Porton Pharma Solutions Competitive Strengths & Weaknesses
7.15 Sinopep
7.15.1 Sinopep Details
7.15.2 Sinopep Major Business
7.15.3 Sinopep Intermediate CDMO Product and Services
7.15.4 Sinopep Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Sinopep Recent Developments/Updates
7.15.6 Sinopep Competitive Strengths & Weaknesses
7.16 Chongqing Huapont Pharmaceutical
7.16.1 Chongqing Huapont Pharmaceutical Details
7.16.2 Chongqing Huapont Pharmaceutical Major Business
7.16.3 Chongqing Huapont Pharmaceutical Intermediate CDMO Product and Services
7.16.4 Chongqing Huapont Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
7.16.6 Chongqing Huapont Pharmaceutical Competitive Strengths & Weaknesses
7.17 Langhua Pharmaceutical
7.17.1 Langhua Pharmaceutical Details
7.17.2 Langhua Pharmaceutical Major Business
7.17.3 Langhua Pharmaceutical Intermediate CDMO Product and Services
7.17.4 Langhua Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Langhua Pharmaceutical Recent Developments/Updates
7.17.6 Langhua Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Intermediate CDMO Industry Chain
8.2 Intermediate CDMO Upstream Analysis
8.3 Intermediate CDMO Midstream Analysis
8.4 Intermediate CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Intermediate CDMO Introduction
1.2 World Intermediate CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Intermediate CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Intermediate CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Intermediate CDMO Market Size (2018-2029)
1.3.3 China Intermediate CDMO Market Size (2018-2029)
1.3.4 Europe Intermediate CDMO Market Size (2018-2029)
1.3.5 Japan Intermediate CDMO Market Size (2018-2029)
1.3.6 South Korea Intermediate CDMO Market Size (2018-2029)
1.3.7 ASEAN Intermediate CDMO Market Size (2018-2029)
1.3.8 India Intermediate CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intermediate CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intermediate CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Intermediate CDMO Consumption Value (2018-2029)
2.2 World Intermediate CDMO Consumption Value by Region
2.2.1 World Intermediate CDMO Consumption Value by Region (2018-2023)
2.2.2 World Intermediate CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Intermediate CDMO Consumption Value (2018-2029)
2.4 China Intermediate CDMO Consumption Value (2018-2029)
2.5 Europe Intermediate CDMO Consumption Value (2018-2029)
2.6 Japan Intermediate CDMO Consumption Value (2018-2029)
2.7 South Korea Intermediate CDMO Consumption Value (2018-2029)
2.8 ASEAN Intermediate CDMO Consumption Value (2018-2029)
2.9 India Intermediate CDMO Consumption Value (2018-2029)
3 WORLD INTERMEDIATE CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Intermediate CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Intermediate CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Intermediate CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Intermediate CDMO in 2022
3.3 Intermediate CDMO Company Evaluation Quadrant
3.4 Intermediate CDMO Market: Overall Company Footprint Analysis
3.4.1 Intermediate CDMO Market: Region Footprint
3.4.2 Intermediate CDMO Market: Company Product Type Footprint
3.4.3 Intermediate CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Intermediate CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Intermediate CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Intermediate CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Intermediate CDMO Consumption Value Comparison
4.2.1 United States VS China: Intermediate CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Intermediate CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Intermediate CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Intermediate CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Intermediate CDMO Revenue, (2018-2023)
4.4 China Based Companies Intermediate CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Intermediate CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Intermediate CDMO Revenue, (2018-2023)
4.5 Rest of World Based Intermediate CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Intermediate CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Intermediate CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Intermediate CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antibiotic Intermediates
5.2.2 Antipyretic and Analgesic Intermediate
5.2.3 Cardiovascular System Drug Intermediates
5.2.4 Anticancer Drug Intermediates
5.3 Market Segment by Type
5.3.1 World Intermediate CDMO Market Size by Type (2018-2023)
5.3.2 World Intermediate CDMO Market Size by Type (2024-2029)
5.3.3 World Intermediate CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Intermediate CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Generic Company
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Intermediate CDMO Market Size by Application (2018-2023)
6.3.2 World Intermediate CDMO Market Size by Application (2024-2029)
6.3.3 World Intermediate CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pharmira
7.1.1 Pharmira Details
7.1.2 Pharmira Major Business
7.1.3 Pharmira Intermediate CDMO Product and Services
7.1.4 Pharmira Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Pharmira Recent Developments/Updates
7.1.6 Pharmira Competitive Strengths & Weaknesses
7.2 AGC Inc
7.2.1 AGC Inc Details
7.2.2 AGC Inc Major Business
7.2.3 AGC Inc Intermediate CDMO Product and Services
7.2.4 AGC Inc Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 AGC Inc Recent Developments/Updates
7.2.6 AGC Inc Competitive Strengths & Weaknesses
7.3 Blue Jet Healthcare
7.3.1 Blue Jet Healthcare Details
7.3.2 Blue Jet Healthcare Major Business
7.3.3 Blue Jet Healthcare Intermediate CDMO Product and Services
7.3.4 Blue Jet Healthcare Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Blue Jet Healthcare Recent Developments/Updates
7.3.6 Blue Jet Healthcare Competitive Strengths & Weaknesses
7.4 Drug Discovery Alliances
7.4.1 Drug Discovery Alliances Details
7.4.2 Drug Discovery Alliances Major Business
7.4.3 Drug Discovery Alliances Intermediate CDMO Product and Services
7.4.4 Drug Discovery Alliances Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Drug Discovery Alliances Recent Developments/Updates
7.4.6 Drug Discovery Alliances Competitive Strengths & Weaknesses
7.5 KriSan Biotech
7.5.1 KriSan Biotech Details
7.5.2 KriSan Biotech Major Business
7.5.3 KriSan Biotech Intermediate CDMO Product and Services
7.5.4 KriSan Biotech Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 KriSan Biotech Recent Developments/Updates
7.5.6 KriSan Biotech Competitive Strengths & Weaknesses
7.6 Saurav Chemicals
7.6.1 Saurav Chemicals Details
7.6.2 Saurav Chemicals Major Business
7.6.3 Saurav Chemicals Intermediate CDMO Product and Services
7.6.4 Saurav Chemicals Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Saurav Chemicals Recent Developments/Updates
7.6.6 Saurav Chemicals Competitive Strengths & Weaknesses
7.7 Olon SpA
7.7.1 Olon SpA Details
7.7.2 Olon SpA Major Business
7.7.3 Olon SpA Intermediate CDMO Product and Services
7.7.4 Olon SpA Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Olon SpA Recent Developments/Updates
7.7.6 Olon SpA Competitive Strengths & Weaknesses
7.8 AGC Biologics
7.8.1 AGC Biologics Details
7.8.2 AGC Biologics Major Business
7.8.3 AGC Biologics Intermediate CDMO Product and Services
7.8.4 AGC Biologics Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 AGC Biologics Recent Developments/Updates
7.8.6 AGC Biologics Competitive Strengths & Weaknesses
7.9 Fermion
7.9.1 Fermion Details
7.9.2 Fermion Major Business
7.9.3 Fermion Intermediate CDMO Product and Services
7.9.4 Fermion Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Fermion Recent Developments/Updates
7.9.6 Fermion Competitive Strengths & Weaknesses
7.10 Pfizer CentreOne
7.10.1 Pfizer CentreOne Details
7.10.2 Pfizer CentreOne Major Business
7.10.3 Pfizer CentreOne Intermediate CDMO Product and Services
7.10.4 Pfizer CentreOne Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Pfizer CentreOne Recent Developments/Updates
7.10.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.11 Aspen Holdings
7.11.1 Aspen Holdings Details
7.11.2 Aspen Holdings Major Business
7.11.3 Aspen Holdings Intermediate CDMO Product and Services
7.11.4 Aspen Holdings Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Aspen Holdings Recent Developments/Updates
7.11.6 Aspen Holdings Competitive Strengths & Weaknesses
7.12 Educell
7.12.1 Educell Details
7.12.2 Educell Major Business
7.12.3 Educell Intermediate CDMO Product and Services
7.12.4 Educell Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Educell Recent Developments/Updates
7.12.6 Educell Competitive Strengths & Weaknesses
7.13 Hovione
7.13.1 Hovione Details
7.13.2 Hovione Major Business
7.13.3 Hovione Intermediate CDMO Product and Services
7.13.4 Hovione Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Hovione Recent Developments/Updates
7.13.6 Hovione Competitive Strengths & Weaknesses
7.14 Porton Pharma Solutions
7.14.1 Porton Pharma Solutions Details
7.14.2 Porton Pharma Solutions Major Business
7.14.3 Porton Pharma Solutions Intermediate CDMO Product and Services
7.14.4 Porton Pharma Solutions Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Porton Pharma Solutions Recent Developments/Updates
7.14.6 Porton Pharma Solutions Competitive Strengths & Weaknesses
7.15 Sinopep
7.15.1 Sinopep Details
7.15.2 Sinopep Major Business
7.15.3 Sinopep Intermediate CDMO Product and Services
7.15.4 Sinopep Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Sinopep Recent Developments/Updates
7.15.6 Sinopep Competitive Strengths & Weaknesses
7.16 Chongqing Huapont Pharmaceutical
7.16.1 Chongqing Huapont Pharmaceutical Details
7.16.2 Chongqing Huapont Pharmaceutical Major Business
7.16.3 Chongqing Huapont Pharmaceutical Intermediate CDMO Product and Services
7.16.4 Chongqing Huapont Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
7.16.6 Chongqing Huapont Pharmaceutical Competitive Strengths & Weaknesses
7.17 Langhua Pharmaceutical
7.17.1 Langhua Pharmaceutical Details
7.17.2 Langhua Pharmaceutical Major Business
7.17.3 Langhua Pharmaceutical Intermediate CDMO Product and Services
7.17.4 Langhua Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Langhua Pharmaceutical Recent Developments/Updates
7.17.6 Langhua Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Intermediate CDMO Industry Chain
8.2 Intermediate CDMO Upstream Analysis
8.3 Intermediate CDMO Midstream Analysis
8.4 Intermediate CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Intermediate CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Intermediate CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Intermediate CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Intermediate CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Intermediate CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Intermediate CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Intermediate CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Intermediate CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Intermediate CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Intermediate CDMO Players in 2022
Table 12. World Intermediate CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Intermediate CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Intermediate CDMO Player
Table 15. Intermediate CDMO Market: Company Product Type Footprint
Table 16. Intermediate CDMO Market: Company Product Application Footprint
Table 17. Intermediate CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Intermediate CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Intermediate CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Intermediate CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Intermediate CDMO Revenue Market Share (2018-2023)
Table 23. China Based Intermediate CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Intermediate CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Intermediate CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Intermediate CDMO Revenue Market Share (2018-2023)
Table 29. World Intermediate CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Intermediate CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Intermediate CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Intermediate CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Intermediate CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Intermediate CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Pharmira Basic Information, Area Served and Competitors
Table 36. Pharmira Major Business
Table 37. Pharmira Intermediate CDMO Product and Services
Table 38. Pharmira Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pharmira Recent Developments/Updates
Table 40. Pharmira Competitive Strengths & Weaknesses
Table 41. AGC Inc Basic Information, Area Served and Competitors
Table 42. AGC Inc Major Business
Table 43. AGC Inc Intermediate CDMO Product and Services
Table 44. AGC Inc Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. AGC Inc Recent Developments/Updates
Table 46. AGC Inc Competitive Strengths & Weaknesses
Table 47. Blue Jet Healthcare Basic Information, Area Served and Competitors
Table 48. Blue Jet Healthcare Major Business
Table 49. Blue Jet Healthcare Intermediate CDMO Product and Services
Table 50. Blue Jet Healthcare Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Blue Jet Healthcare Recent Developments/Updates
Table 52. Blue Jet Healthcare Competitive Strengths & Weaknesses
Table 53. Drug Discovery Alliances Basic Information, Area Served and Competitors
Table 54. Drug Discovery Alliances Major Business
Table 55. Drug Discovery Alliances Intermediate CDMO Product and Services
Table 56. Drug Discovery Alliances Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Drug Discovery Alliances Recent Developments/Updates
Table 58. Drug Discovery Alliances Competitive Strengths & Weaknesses
Table 59. KriSan Biotech Basic Information, Area Served and Competitors
Table 60. KriSan Biotech Major Business
Table 61. KriSan Biotech Intermediate CDMO Product and Services
Table 62. KriSan Biotech Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. KriSan Biotech Recent Developments/Updates
Table 64. KriSan Biotech Competitive Strengths & Weaknesses
Table 65. Saurav Chemicals Basic Information, Area Served and Competitors
Table 66. Saurav Chemicals Major Business
Table 67. Saurav Chemicals Intermediate CDMO Product and Services
Table 68. Saurav Chemicals Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Saurav Chemicals Recent Developments/Updates
Table 70. Saurav Chemicals Competitive Strengths & Weaknesses
Table 71. Olon SpA Basic Information, Area Served and Competitors
Table 72. Olon SpA Major Business
Table 73. Olon SpA Intermediate CDMO Product and Services
Table 74. Olon SpA Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Olon SpA Recent Developments/Updates
Table 76. Olon SpA Competitive Strengths & Weaknesses
Table 77. AGC Biologics Basic Information, Area Served and Competitors
Table 78. AGC Biologics Major Business
Table 79. AGC Biologics Intermediate CDMO Product and Services
Table 80. AGC Biologics Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. AGC Biologics Recent Developments/Updates
Table 82. AGC Biologics Competitive Strengths & Weaknesses
Table 83. Fermion Basic Information, Area Served and Competitors
Table 84. Fermion Major Business
Table 85. Fermion Intermediate CDMO Product and Services
Table 86. Fermion Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Fermion Recent Developments/Updates
Table 88. Fermion Competitive Strengths & Weaknesses
Table 89. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 90. Pfizer CentreOne Major Business
Table 91. Pfizer CentreOne Intermediate CDMO Product and Services
Table 92. Pfizer CentreOne Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Pfizer CentreOne Recent Developments/Updates
Table 94. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 95. Aspen Holdings Basic Information, Area Served and Competitors
Table 96. Aspen Holdings Major Business
Table 97. Aspen Holdings Intermediate CDMO Product and Services
Table 98. Aspen Holdings Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Aspen Holdings Recent Developments/Updates
Table 100. Aspen Holdings Competitive Strengths & Weaknesses
Table 101. Educell Basic Information, Area Served and Competitors
Table 102. Educell Major Business
Table 103. Educell Intermediate CDMO Product and Services
Table 104. Educell Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Educell Recent Developments/Updates
Table 106. Educell Competitive Strengths & Weaknesses
Table 107. Hovione Basic Information, Area Served and Competitors
Table 108. Hovione Major Business
Table 109. Hovione Intermediate CDMO Product and Services
Table 110. Hovione Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Hovione Recent Developments/Updates
Table 112. Hovione Competitive Strengths & Weaknesses
Table 113. Porton Pharma Solutions Basic Information, Area Served and Competitors
Table 114. Porton Pharma Solutions Major Business
Table 115. Porton Pharma Solutions Intermediate CDMO Product and Services
Table 116. Porton Pharma Solutions Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Porton Pharma Solutions Recent Developments/Updates
Table 118. Porton Pharma Solutions Competitive Strengths & Weaknesses
Table 119. Sinopep Basic Information, Area Served and Competitors
Table 120. Sinopep Major Business
Table 121. Sinopep Intermediate CDMO Product and Services
Table 122. Sinopep Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Sinopep Recent Developments/Updates
Table 124. Sinopep Competitive Strengths & Weaknesses
Table 125. Chongqing Huapont Pharmaceutical Basic Information, Area Served and Competitors
Table 126. Chongqing Huapont Pharmaceutical Major Business
Table 127. Chongqing Huapont Pharmaceutical Intermediate CDMO Product and Services
Table 128. Chongqing Huapont Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Chongqing Huapont Pharmaceutical Recent Developments/Updates
Table 130. Langhua Pharmaceutical Basic Information, Area Served and Competitors
Table 131. Langhua Pharmaceutical Major Business
Table 132. Langhua Pharmaceutical Intermediate CDMO Product and Services
Table 133. Langhua Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 134. Global Key Players of Intermediate CDMO Upstream (Raw Materials)
Table 135. Intermediate CDMO Typical Customers
Table 1. World Intermediate CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Intermediate CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Intermediate CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Intermediate CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Intermediate CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Intermediate CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Intermediate CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Intermediate CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Intermediate CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Intermediate CDMO Players in 2022
Table 12. World Intermediate CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Intermediate CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Intermediate CDMO Player
Table 15. Intermediate CDMO Market: Company Product Type Footprint
Table 16. Intermediate CDMO Market: Company Product Application Footprint
Table 17. Intermediate CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Intermediate CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Intermediate CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Intermediate CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Intermediate CDMO Revenue Market Share (2018-2023)
Table 23. China Based Intermediate CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Intermediate CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Intermediate CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Intermediate CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Intermediate CDMO Revenue Market Share (2018-2023)
Table 29. World Intermediate CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Intermediate CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Intermediate CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Intermediate CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Intermediate CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Intermediate CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Pharmira Basic Information, Area Served and Competitors
Table 36. Pharmira Major Business
Table 37. Pharmira Intermediate CDMO Product and Services
Table 38. Pharmira Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pharmira Recent Developments/Updates
Table 40. Pharmira Competitive Strengths & Weaknesses
Table 41. AGC Inc Basic Information, Area Served and Competitors
Table 42. AGC Inc Major Business
Table 43. AGC Inc Intermediate CDMO Product and Services
Table 44. AGC Inc Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. AGC Inc Recent Developments/Updates
Table 46. AGC Inc Competitive Strengths & Weaknesses
Table 47. Blue Jet Healthcare Basic Information, Area Served and Competitors
Table 48. Blue Jet Healthcare Major Business
Table 49. Blue Jet Healthcare Intermediate CDMO Product and Services
Table 50. Blue Jet Healthcare Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Blue Jet Healthcare Recent Developments/Updates
Table 52. Blue Jet Healthcare Competitive Strengths & Weaknesses
Table 53. Drug Discovery Alliances Basic Information, Area Served and Competitors
Table 54. Drug Discovery Alliances Major Business
Table 55. Drug Discovery Alliances Intermediate CDMO Product and Services
Table 56. Drug Discovery Alliances Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Drug Discovery Alliances Recent Developments/Updates
Table 58. Drug Discovery Alliances Competitive Strengths & Weaknesses
Table 59. KriSan Biotech Basic Information, Area Served and Competitors
Table 60. KriSan Biotech Major Business
Table 61. KriSan Biotech Intermediate CDMO Product and Services
Table 62. KriSan Biotech Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. KriSan Biotech Recent Developments/Updates
Table 64. KriSan Biotech Competitive Strengths & Weaknesses
Table 65. Saurav Chemicals Basic Information, Area Served and Competitors
Table 66. Saurav Chemicals Major Business
Table 67. Saurav Chemicals Intermediate CDMO Product and Services
Table 68. Saurav Chemicals Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Saurav Chemicals Recent Developments/Updates
Table 70. Saurav Chemicals Competitive Strengths & Weaknesses
Table 71. Olon SpA Basic Information, Area Served and Competitors
Table 72. Olon SpA Major Business
Table 73. Olon SpA Intermediate CDMO Product and Services
Table 74. Olon SpA Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Olon SpA Recent Developments/Updates
Table 76. Olon SpA Competitive Strengths & Weaknesses
Table 77. AGC Biologics Basic Information, Area Served and Competitors
Table 78. AGC Biologics Major Business
Table 79. AGC Biologics Intermediate CDMO Product and Services
Table 80. AGC Biologics Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. AGC Biologics Recent Developments/Updates
Table 82. AGC Biologics Competitive Strengths & Weaknesses
Table 83. Fermion Basic Information, Area Served and Competitors
Table 84. Fermion Major Business
Table 85. Fermion Intermediate CDMO Product and Services
Table 86. Fermion Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Fermion Recent Developments/Updates
Table 88. Fermion Competitive Strengths & Weaknesses
Table 89. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 90. Pfizer CentreOne Major Business
Table 91. Pfizer CentreOne Intermediate CDMO Product and Services
Table 92. Pfizer CentreOne Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Pfizer CentreOne Recent Developments/Updates
Table 94. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 95. Aspen Holdings Basic Information, Area Served and Competitors
Table 96. Aspen Holdings Major Business
Table 97. Aspen Holdings Intermediate CDMO Product and Services
Table 98. Aspen Holdings Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Aspen Holdings Recent Developments/Updates
Table 100. Aspen Holdings Competitive Strengths & Weaknesses
Table 101. Educell Basic Information, Area Served and Competitors
Table 102. Educell Major Business
Table 103. Educell Intermediate CDMO Product and Services
Table 104. Educell Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Educell Recent Developments/Updates
Table 106. Educell Competitive Strengths & Weaknesses
Table 107. Hovione Basic Information, Area Served and Competitors
Table 108. Hovione Major Business
Table 109. Hovione Intermediate CDMO Product and Services
Table 110. Hovione Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Hovione Recent Developments/Updates
Table 112. Hovione Competitive Strengths & Weaknesses
Table 113. Porton Pharma Solutions Basic Information, Area Served and Competitors
Table 114. Porton Pharma Solutions Major Business
Table 115. Porton Pharma Solutions Intermediate CDMO Product and Services
Table 116. Porton Pharma Solutions Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Porton Pharma Solutions Recent Developments/Updates
Table 118. Porton Pharma Solutions Competitive Strengths & Weaknesses
Table 119. Sinopep Basic Information, Area Served and Competitors
Table 120. Sinopep Major Business
Table 121. Sinopep Intermediate CDMO Product and Services
Table 122. Sinopep Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Sinopep Recent Developments/Updates
Table 124. Sinopep Competitive Strengths & Weaknesses
Table 125. Chongqing Huapont Pharmaceutical Basic Information, Area Served and Competitors
Table 126. Chongqing Huapont Pharmaceutical Major Business
Table 127. Chongqing Huapont Pharmaceutical Intermediate CDMO Product and Services
Table 128. Chongqing Huapont Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Chongqing Huapont Pharmaceutical Recent Developments/Updates
Table 130. Langhua Pharmaceutical Basic Information, Area Served and Competitors
Table 131. Langhua Pharmaceutical Major Business
Table 132. Langhua Pharmaceutical Intermediate CDMO Product and Services
Table 133. Langhua Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 134. Global Key Players of Intermediate CDMO Upstream (Raw Materials)
Table 135. Intermediate CDMO Typical Customers
LIST OF FIGURES
Figure 1. Intermediate CDMO Picture
Figure 2. World Intermediate CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Intermediate CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Intermediate CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Intermediate CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Intermediate CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Intermediate CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Intermediate CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Intermediate CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Intermediate CDMO Markets in 2022
Figure 27. United States VS China: Intermediate CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Intermediate CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Intermediate CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Intermediate CDMO Market Size Market Share by Type in 2022
Figure 31. Antibiotic Intermediates
Figure 32. Antipyretic and Analgesic Intermediate
Figure 33. Cardiovascular System Drug Intermediates
Figure 34. Anticancer Drug Intermediates
Figure 35. World Intermediate CDMO Market Size Market Share by Type (2018-2029)
Figure 36. World Intermediate CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Intermediate CDMO Market Size Market Share by Application in 2022
Figure 38. Pharmaceutical Company
Figure 39. Biotechnology Company
Figure 40. Generic Company
Figure 41. Others
Figure 42. Intermediate CDMO Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Intermediate CDMO Picture
Figure 2. World Intermediate CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Intermediate CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Intermediate CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Intermediate CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Intermediate CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Intermediate CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Intermediate CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Intermediate CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Intermediate CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Intermediate CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Intermediate CDMO Markets in 2022
Figure 27. United States VS China: Intermediate CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Intermediate CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Intermediate CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Intermediate CDMO Market Size Market Share by Type in 2022
Figure 31. Antibiotic Intermediates
Figure 32. Antipyretic and Analgesic Intermediate
Figure 33. Cardiovascular System Drug Intermediates
Figure 34. Anticancer Drug Intermediates
Figure 35. World Intermediate CDMO Market Size Market Share by Type (2018-2029)
Figure 36. World Intermediate CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Intermediate CDMO Market Size Market Share by Application in 2022
Figure 38. Pharmaceutical Company
Figure 39. Biotechnology Company
Figure 40. Generic Company
Figure 41. Others
Figure 42. Intermediate CDMO Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
